Question 1

Does Wealth Enhancement Advisory Services own HRTX stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Wealth Enhancement Advisory Services holds 29,067 shares of HRTX (Heron Therapeutics), worth $10,412.

Question 2

How many shares of HRTX does Wealth Enhancement Advisory Services own?

Accepted Answer

As of its Q3 2026 13F, Wealth Enhancement Advisory Services holds 29,067 shares of HRTX (Heron Therapeutics).

Question 3

What is Wealth Enhancement Advisory Services' HRTX position worth?

Accepted Answer

As of its Q3 2026 13F, Wealth Enhancement Advisory Services' HRTX position is worth $10,412.

Question 4

Is Wealth Enhancement Advisory Services buying or selling HRTX?

Accepted Answer

In Q3 2026, Wealth Enhancement Advisory Services reduced its HRTX position by 3,330 shares (-10.3%).

Question 5

When did Wealth Enhancement Advisory Services first buy HRTX?

Accepted Answer

Wealth Enhancement Advisory Services first reported HRTX in its Q3 2023 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	29,067	-10.3%	$10,412	0.0%	$0.31	0
2026-Q2	Increased	32,397	+95.1%	$13,425	0.0%	$0.43	19
2026-Q1	New	16,604	—	$13,270	0.0%	$0.80	27
2025-Q4	Exited	0	-100.0%	$0	0.0%	$1.30	0
2025-Q3	Decreased	25,577	-31.1%	$33,762	0.0%	$1.26	0
2025-Q2	Increased	37,128	+4.3%	$81,682	0.0%	$2.07	22
2025-Q1	Increased	35,616	+1.4%	$78,357	0.0%	$2.20	22
2024-Q4	Decreased	35,134	-22.4%	$53,755	0.0%	$1.53	0
2024-Q3	Increased	45,273	+21.2%	$90,093	0.0%	$1.99	26